Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
3270 participants
OBSERVATIONAL
2024-01-01
2024-07-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prediction of PaO2 Values Using the PRoPERLy II Database
NCT06589427
PRotective VENTilation in Patients Without ARDS
NCT02153294
Clinical Characteristics and Outcomes of Patients Requiring Mechanical Ventilation in an ICU- a Registry Based Study
NCT06890936
PRactice of VENTilation in Critically Ill PEDiatric Patients
NCT06220825
Helmet NIV vs. CPAP vs. High-flow Nasal Oxygen in Hypoxemic Respiratory Failure
NCT05089695
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients receiving invasive ventilation
Patients receiving invasive ventilation, included in PRoVENT, PRoVENT-iMiC, and ENIO
Invasive ventilation
Invasive ventilation and respiratory support
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Invasive ventilation
Invasive ventilation and respiratory support
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. Marcus J. Schultz
Prof. Dr
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marcus J Schultz, Prof
Role: PRINCIPAL_INVESTIGATOR
Amsterdam UMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRIME-NEU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.